{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "xwi9mzFPPDv7"
   },
   "source": [
    "# Identifying Entities in Healthcare Data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "3wwzoMzrUDtr"
   },
   "source": [
    "## Workspace set up: Import and Install useful packages."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "metadata": {
    "id": "T4hxafMCE1nn"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pycrf in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (0.0.1)\n",
      "Requirement already satisfied: sklearn-crfsuite in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (0.3.6)\n",
      "Requirement already satisfied: six in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (from sklearn-crfsuite) (1.16.0)\n",
      "Requirement already satisfied: tqdm>=2.0 in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (from sklearn-crfsuite) (4.64.0)\n",
      "Requirement already satisfied: python-crfsuite>=0.8.3 in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (from sklearn-crfsuite) (0.9.9)\n",
      "Requirement already satisfied: tabulate in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (from sklearn-crfsuite) (0.8.9)\n",
      "Requirement already satisfied: colorama in c:\\users\\rakesh panigrahy\\anaconda3\\lib\\site-packages (from tqdm>=2.0->sklearn-crfsuite) (0.4.6)\n"
     ]
    }
   ],
   "source": [
    "!pip install pycrf\n",
    "!pip install sklearn-crfsuite\n",
    "\n",
    "import spacy\n",
    "import sklearn_crfsuite\n",
    "from sklearn_crfsuite import metrics\n",
    "\n",
    "model = spacy.load(\"en_core_web_sm\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "bE9Hwb3AUHwG"
   },
   "source": [
    "## Data Preprocessing\n",
    "\n",
    "The dataset provided is in the form of one word per line. Let's understand the format of data below:\n",
    "- Suppose there are *x* words in a sentence, then there will be *x* continuous lines with one word in each line. \n",
    "- Further, the two sentences are separated by empty lines. The labels for the data follow the same format.\n",
    "\n",
    "**We need to pre-process the data to recover the complete sentences and their labels.**\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "nBU_BNUuK8tm"
   },
   "source": [
    "### Construct the proper sentences from individual words and print the 5 sentences."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "b4OjXEhjhkCW"
   },
   "source": [
    "![image.png](data:image/png;base64,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)\n",
    "\n",
    "![image.png](data:image/png;base64,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)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "metadata": {
    "id": "bz6czVx9R6WJ"
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import nltk\n",
    "import spacy\n",
    "import sklearn_crfsuite\n",
    "from sklearn_crfsuite import metrics\n",
    "model = spacy.load(\"en_core_web_sm\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {
    "id": "TE31q8yxVdU-"
   },
   "outputs": [],
   "source": [
    "with open('train_sent', 'r') as train_sent_file:\n",
    "  train_sentences = train_sent_file.readlines()\n",
    "\n",
    "with open('train_label', 'r') as train_labels_file:\n",
    "  train_labels = train_labels_file.readlines()\n",
    "\n",
    "with open('test_sent', 'r') as test_sent_file:\n",
    "  test_sentences = test_sent_file.readlines()\n",
    "\n",
    "with open('test_label', 'r') as test_labels_file:\n",
    "  test_labels = test_labels_file.readlines()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {
    "id": "k4gdPBHwLdNX"
   },
   "outputs": [],
   "source": [
    "train_sentences_list = []\n",
    "test_sentences_list = []\n",
    "\n",
    "train_labels_list = []\n",
    "test_labels_list = []\n",
    "\n",
    "sentence = ''\n",
    "labels = ''\n",
    "counter = 0\n",
    "for w in train_sentences:\n",
    "    sentence += w\n",
    "    labels += train_labels[counter]\n",
    "    if w == '\\n':\n",
    "        sentence = sentence.replace('\\n', ' ')\n",
    "        labels = labels.replace('\\n', ' ')\n",
    "        train_sentences_list.append(sentence.strip())\n",
    "        train_labels_list.append(labels.strip())\n",
    "        sentence = ''\n",
    "        labels = ''\n",
    "    counter += 1\n",
    "    \n",
    "sentence = ''\n",
    "labels = ''\n",
    "counter = 0 \n",
    "for w in test_sentences:\n",
    "    sentence += w\n",
    "    labels += test_labels[counter]\n",
    "    if w == '\\n':\n",
    "        sentence = sentence.replace('\\n', ' ')\n",
    "        labels = labels.replace('\\n', ' ')\n",
    "        test_sentences_list.append(sentence.strip())\n",
    "        test_labels_list.append(labels.strip())\n",
    "        sentence = ''\n",
    "        labels = ''\n",
    "    counter += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'The total cesarean rate was 14.4 % ( 344 of 2395 ) , and the primary rate was 11.4 % ( 244 of 2144 )'"
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_sentences_list[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'O O O O O O O O O O O O O O O O O O O O O O O O O'"
      ]
     },
     "execution_count": 142,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_labels_list[1]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "urCxIOBTMBwG"
   },
   "source": [
    "### Count the number of sentences in the processed train and test dataset "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {
    "id": "zwa18H_IMFXV"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2599\n",
      "1056\n"
     ]
    }
   ],
   "source": [
    "print(len(train_sentences_list))\n",
    "print(len(test_sentences_list))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "Jjg2DK7hLcO_"
   },
   "source": [
    "### Count the number of lines of labels in the processed train and test dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "metadata": {
    "id": "unXoD2bWLPZD"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2599\n",
      "1056\n"
     ]
    }
   ],
   "source": [
    "print(len(train_labels_list))\n",
    "print(len(test_labels_list))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "r9Hy2tECbd9a"
   },
   "source": [
    "## Concept Identification\n",
    "\n",
    "We will first explore what are the various concepts present in the dataset. For this, we will use PoS Tagging. \n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "3YGpfOK7Mk3X"
   },
   "source": [
    "### Extract those tokens which have NOUN or PROPN as their PoS tag and find their frequency"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {
    "id": "7w8nJSPlZqjw"
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3655"
      ]
     },
     "execution_count": 145,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "document = train_sentences_list + test_sentences_list\n",
    "len(document)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "-SQG8wRxMo6A"
   },
   "source": [
    "### Print the top 25 most common tokens with NOUN or PROPN PoS tags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 146,
   "metadata": {
    "id": "DhDY4jjoawTa"
   },
   "outputs": [],
   "source": [
    "tokens = []\n",
    "for sent in document:\n",
    "    doc = model(sent)\n",
    "    for tok in doc:\n",
    "        if tok.pos_==\"NOUN\" or tok.pos_ == 'PROPN':\n",
    "            tokens.append(tok.lemma_.lower())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 147,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "patient         568\n",
       "treatment       316\n",
       "%               247\n",
       "study           236\n",
       "cancer          226\n",
       "cell            203\n",
       "therapy         182\n",
       "effect          181\n",
       "disease         170\n",
       "group           145\n",
       "case            132\n",
       "result          121\n",
       "lung            120\n",
       "gene            111\n",
       "year            105\n",
       "rate            103\n",
       "chemotherapy     91\n",
       "use              91\n",
       "trial            90\n",
       "woman            89\n",
       "conclusion       89\n",
       "analysis         86\n",
       "protein          82\n",
       "response         81\n",
       "risk             78\n",
       "dtype: int64"
      ]
     },
     "execution_count": 147,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokens=pd.Series(tokens)\n",
    "tokens.value_counts().head(25)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "bnfAlKgA5fd4"
   },
   "source": [
    "## Defining features for CRF\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "metadata": {
    "id": "aS6P1Gog3JMf"
   },
   "outputs": [],
   "source": [
    "# Let's define the features to get the feature value for one word.\n",
    "def getFeaturesForOneWord(sentence, pos):\n",
    "  word = sentence[pos]\n",
    "\n",
    "  features = [\n",
    "    'word.lower=' + word.lower(), # serves as word id\n",
    "    'word[-3:]=' + word[-3:],     # last three characters\n",
    "    'word[-2:]=' + word[-2:],     # last two characters\n",
    "    'word.isupper=%s' % word.isupper(),  # is the word in all uppercase\n",
    "    'word.isdigit=%s' % word.isdigit(),  # is the word a number\n",
    "    'words.startsWithCapital=%s' % word[0].isupper() # is the word starting with a capital letter\n",
    "  ]\n",
    "\n",
    "  if(pos > 0):\n",
    "    prev_word = sentence[pos-1]\n",
    "    features.extend([\n",
    "    'prev_word.lower=' + prev_word.lower(), \n",
    "    'prev_word.isupper=%s' % prev_word.isupper(),\n",
    "    'prev_word.isdigit=%s' % prev_word.isdigit(),\n",
    "    'prev_words.startsWithCapital=%s' % prev_word[0].isupper()\n",
    "  ])\n",
    "  else:\n",
    "    features.append('BEG') # feature to track begin of sentence \n",
    "\n",
    "  if(pos == len(sentence)-1):\n",
    "    features.append('END') # feature to track end of sentence\n",
    "\n",
    "  return features"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "haBEOsZGKhb9"
   },
   "source": [
    "## Getting the features"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "Fwb8YUdlNcG1"
   },
   "source": [
    "### Write a code/function to get the features for a sentence"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 149,
   "metadata": {
    "id": "emBIm5uK7vtK"
   },
   "outputs": [],
   "source": [
    "# Write a code to get features for a sentence.\n",
    "def getFeaturesForOneSentence(sentence):\n",
    "  sentence_list = sentence.split()\n",
    "  return [getFeaturesForOneWord(sentence_list, pos) for pos in range(len(sentence_list))]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "A7fs-B8CNein"
   },
   "source": [
    "### Write a code/function to get the labels of a sentence"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "metadata": {
    "id": "tiA-A_ws8I8-"
   },
   "outputs": [],
   "source": [
    "# Write a code to get the labels for a sentence.\n",
    "def getLabelsInListForOneSentence(labels):\n",
    "  return labels.split()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "QG6hYY6rNjS8"
   },
   "source": [
    "## Define input and target variables\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "DZmjKbXgN44o"
   },
   "source": [
    "Correctly computing X and Y sequence matrices for training and test data.\n",
    "Check that both sentences and labels are processed"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "U1C4djFXNpqN"
   },
   "source": [
    "### Define the features' values for each sentence as input variable  for CRF model in test and the train dataset "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "metadata": {
    "id": "8Nuz-MjW8LWm"
   },
   "outputs": [],
   "source": [
    "X_train = [getFeaturesForOneSentence(sentence) for sentence in train_sentences_list]\n",
    "X_test = [getFeaturesForOneSentence(sentence) for sentence in test_sentences_list]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "q88-s6BQNr0M"
   },
   "source": [
    "### Define the labels as the target variable for test and the train dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 152,
   "metadata": {
    "id": "HrzLkWs0Nvx4"
   },
   "outputs": [],
   "source": [
    "Y_train = [getLabelsInListForOneSentence(labels) for labels in train_labels_list]\n",
    "Y_test = [getLabelsInListForOneSentence(labels) for labels in test_labels_list]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "YrIAz8gqN_Js"
   },
   "source": [
    "## Build the CRF Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "metadata": {
    "id": "k2oGSiqQ8Otd"
   },
   "outputs": [],
   "source": [
    "# Build the CRF model.\n",
    "import sklearn_crfsuite\n",
    "\n",
    "from sklearn_crfsuite import metrics\n",
    "\n",
    "crf = sklearn_crfsuite.CRF(max_iterations=100)\n",
    "try:\n",
    "    crf.fit(X_train, Y_train)\n",
    "except AttributeError:\n",
    "    pass"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "5VPFrPZJOJMq"
   },
   "source": [
    "## Evaluation"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "84gUagMZOP9B"
   },
   "source": [
    "### Predict the labels of each of the tokens in each sentence of the test dataset that has been pre processed earlier."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "metadata": {
    "id": "D_sDJs1n8-sI"
   },
   "outputs": [],
   "source": [
    "Y_pred = crf.predict(X_test)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "qIneYrqZOUiJ"
   },
   "source": [
    "### Calculate the f1 score using the actual labels and the predicted labels of the test dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "metadata": {
    "id": "Lr_JNIgrOTcr"
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.9042560946986944"
      ]
     },
     "execution_count": 155,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metrics.flat_f1_score(Y_test, Y_pred, average='weighted')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "ORDyDw6sYHf5"
   },
   "source": [
    "## Identifying Diseases and Treatments using Custom NER\n",
    "\n",
    "We now use the CRF model's prediction to prepare a record of diseases identified in the corpus and treatments used for the diseases.\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "V9aOa7LEOcWu"
   },
   "source": [
    "### Create the logic to get all the predicted treatments (T) labels corresponding to each disease (D) label in the test dataset."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "sWxZ2TaOqN-u"
   },
   "source": [
    "![image.png](data:image/png;base64,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)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 156,
   "metadata": {
    "id": "6reMqClg97Ry"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['<', 'TO_SEE', '>', 'CONTEXT', ':', 'There', 'is', 'a', 'substantial', 'risk', 'of', 'a', 'second', 'cancer', 'for', 'persons', 'with', 'hereditary', 'retinoblastoma', ',', 'which', 'is', 'enhanced', 'by', 'radiotherapy']\n",
      "hereditary\n",
      "retinoblastoma\n",
      "radiotherapy\n",
      "['METHODS', ':', 'The', 'effect', 'of', 'roxithromycin', 'was', 'assessed', 'in', 'a', 'double-blind', ',', 'randomised', ',', 'prospective', ',', 'multicentre', ',', 'parallel-group', ',', 'placebo-controlled', 'pilot', 'study', 'of', '202', 'patients', 'with', 'unstable', 'angina', 'or', 'non-Q-wave', 'myocardial', 'infarction']\n",
      "roxithromycin\n",
      "unstable\n",
      "angina\n",
      "or\n",
      "non-Q-wave\n",
      "myocardial\n",
      "infarction\n",
      "['INTERPRETATION', ':', 'Antichlamydial', 'antibiotics', 'may', 'be', 'useful', 'in', 'therapeutic', 'intervention', 'in', 'addition', 'to', 'standard', 'medication', 'in', 'patients', 'with', 'coronary-artery', 'disease']\n",
      "Antichlamydial\n",
      "antibiotics\n",
      "coronary-artery\n",
      "disease\n",
      "['<', 'TO_SEE', '>', 'FINDINGS', ':', 'G-CSF', 'therapy', 'was', 'associated', 'with', 'earlier', 'eradication', 'of', 'pathogens', 'from', 'the', 'infected', 'ulcer', '(', 'median', '4', '(', 'range', '2-10', ')', 'vs', '8', '(', '2-79', ')', 'days', 'in', 'the', 'placebo', 'group', ';', 'p', '=', '0.02', ')', ',', 'quicker', 'resolution', 'of', 'cellulitis', '<', '(', '7', '(', '5-20', ')', 'vs', '12', '(', '5-93', ')', 'days', ';', 'p', '=', '0.03', ')', ',', 'shorter', 'hospital', 'stay', '(', '10', '(', '7-31', ')', 'vs', '17.5', '(', '9-100', ')', 'days', ';', 'p', '=', '0.02', ')', ',', 'and', 'a', 'shorter', 'duration', 'of', 'intravenous', 'antibiotic', 'treatment', '(', '8.5', '(', '5-30', ')', 'vs', '14.5', '(', '8-63', ')', 'days', ';', 'p', '=', '0.02', ')']\n",
      "G-CSF\n",
      "therapy\n",
      "cellulitis\n",
      "intravenous\n",
      "antibiotic\n",
      "treatment\n",
      "['INTERPRETATION', ':', 'G-CSF', 'treatment', 'was', 'associated', 'with', 'improved', 'clinical', 'outcome', 'of', 'foot', 'infection', 'in', 'diabetic', 'patients']\n",
      "G-CSF\n",
      "treatment\n",
      "foot\n",
      "infection\n",
      "['Ropinirole', 'monotherapy', 'is', 'an', 'effective', 'and', 'well-tolerated', 'therapeutic', 'option', 'for', 'treatment', 'of', 'early', 'Parkinson', \"'s\", 'disease']\n",
      "Ropinirole\n",
      "monotherapy\n",
      "early\n",
      "Parkinson\n",
      "'s\n",
      "disease\n",
      "['MATERIALS', 'AND', 'METHODS', ':', 'The', 'panel', 'searched', 'the', 'MEDLINE', 'data', 'base', 'for', 'all', 'articles', 'through', '1993', 'on', 'surgical', 'treatment', 'of', 'female', 'stress', 'urinary', 'incontinence']\n",
      "surgical\n",
      "treatment\n",
      "female\n",
      "stress\n",
      "urinary\n",
      "incontinence\n",
      "['The', 'evidence', 'supports', 'surgery', 'as', 'initial', 'therapy', 'and', 'as', 'a', 'secondary', 'form', 'of', 'therapy', 'after', 'failure', 'of', 'other', 'treatments', 'for', 'stress', 'urinary', 'incontinence']\n",
      "therapy\n",
      "stress\n",
      "urinary\n",
      "incontinence\n",
      "['We', 'hypothesize', 'that', 'there', 'is', 'a', 'higher', 'incidence', 'of', 'preeclampsia', '(', 'proteinuric', 'hypertension', ')', 'in', 'women', 'conceiving', 'by', 'intrauterine', 'insemination', 'with', 'donor', 'sperm', 'versus', 'intrauterine', 'insemination', 'with', 'partner', 'sperm']\n",
      "preeclampsia\n",
      "(\n",
      "proteinuric\n",
      "hypertension\n",
      ")\n",
      "intrauterine\n",
      "insemination\n",
      "with\n",
      "donor\n",
      "sperm\n",
      "versus\n",
      "intrauterine\n",
      "insemination\n",
      "['<', 'TO_SEE', '>', 'BACKGROUND', ':', 'The', 'cause', 'of', 'severe', 'acquired', 'hyperammonemia', ',', 'an', 'uncommon', 'but', 'often', 'fatal', 'complication', 'of', 'organ', 'transplantation', 'and', 'chemotherapy', 'for', 'cancer', ',', 'is', 'obscure']\n",
      "organ\n",
      "transplantation\n",
      "and\n",
      "chemotherapy\n",
      "cancer\n",
      "['BACKGROUND', ':', 'Thrombolytic', 'treatment', 'has', 'been', 'shown', 'to', 'accelerate', 'resolution', 'of', 'major', 'pulmonary', 'embolism', 'and', 'lead', 'to', 'a', 'rapid', 'improvement', 'of', 'right-side', 'hemodynamics']\n",
      "Thrombolytic\n",
      "treatment\n",
      "major\n",
      "pulmonary\n",
      "embolism\n",
      "right-side\n",
      "hemodynamics\n",
      "['A', '66-year-old', 'male', 'engineer', 'diagnosed', 'with', 'malignant', 'pleural', 'mesothelioma', '4', 'years', 'previously', 'had', 'thoracotomy', ',', 'radiotherapy', ',', 'and', 'chemotherapy']\n",
      "malignant\n",
      "pleural\n",
      "mesothelioma\n",
      "thoracotomy\n",
      ",\n",
      "radiotherapy\n",
      ",\n",
      "and\n",
      "chemotherapy\n",
      "['After', 'completion', 'of', 'chemotherapy', 'and', 'normalization', 'of', 'tumor', 'markers', ',', 'both', 'patients', 'presented', 'with', 'pulmonary', 'symptoms', 'attributable', 'to', 'their', 'massively', 'enlarging', 'mediastinal', 'teratomas', '.']\n",
      "chemotherapy\n",
      "pulmonary\n",
      "symptoms\n",
      "attributable\n",
      "['The', 'efficiency', 'of', 'testicular', 'sperm', 'retrieval', 'by', 'testicular', 'fine', 'needle', 'aspiration', '(', 'TEFNA', ')', 'was', 'compared', 'with', 'open', 'biopsy', 'and', 'testicular', 'sperm', 'extraction', '(', 'TESE', ')', ',', 'in', '37', 'rigorously', 'selected', 'patients', 'with', 'non-obstructive', 'azoospermia']\n",
      "testicular\n",
      "fine\n",
      "needle\n",
      "aspiration\n",
      "(\n",
      "TEFNA\n",
      ")\n",
      "open\n",
      "biopsy\n",
      "and\n",
      "testicular\n",
      "sperm\n",
      "extraction\n",
      "(\n",
      "TESE\n",
      ")\n",
      "non-obstructive\n",
      "azoospermia\n",
      "['Elective', 'surgery', 'for', 'colorectal', 'cancer', 'in', 'the', 'aged', ':', 'a', 'clinical-economical', 'evaluation']\n",
      "Elective\n",
      "surgery\n",
      "colorectal\n",
      "cancer\n",
      "['Non-steroidal', 'anti-inflammatory', 'therapy', 'for', 'bronchial', 'asthma']\n",
      "Non-steroidal\n",
      "anti-inflammatory\n",
      "therapy\n",
      "bronchial\n",
      "asthma\n",
      "['Microelectrode-guided', 'posteroventral', 'pallidotomy', 'for', 'treatment', 'of', 'Parkinson', \"'s\", 'disease', ':', 'postoperative', 'magnetic', 'resonance', 'imaging', 'analysis']\n",
      "Microelectrode-guided\n",
      "posteroventral\n",
      "pallidotomy\n",
      "Parkinson\n",
      "'s\n",
      "disease\n",
      "['Radiotherapy', 'of', 'soft', 'tissue', 'sarcomas']\n",
      "Radiotherapy\n",
      "soft\n",
      "tissue\n",
      "sarcomas\n",
      "['Anaesthesia', 'for', 'laparoscopic', 'cholecystectomy', 'in', 'a', 'patient', 'with', 'Eisenmenger', \"'s\", 'syndrome']\n",
      "laparoscopic\n",
      "cholecystectomy\n",
      "Eisenmenger\n",
      "'s\n",
      "syndrome\n",
      "['Clinical', 'evaluation', 'of', 'adjuvant', 'chemoradiotherapy', 'with', 'CDDP', ',', '5-FU', ',', 'and', 'VP-16', 'for', 'advanced', 'esophageal', 'cancer']\n",
      "adjuvant\n",
      "chemoradiotherapy\n",
      "with\n",
      "CDDP\n",
      "advanced\n",
      "esophageal\n",
      "cancer\n",
      "['Hormone', 'replacement', 'therapy', 'and', 'breast', 'cancer', '.']\n",
      "Hormone\n",
      "replacement\n",
      "therapy\n",
      "breast\n",
      "cancer\n",
      "['Trisomy', '10', 'in', 'leukemia']\n",
      "Trisomy\n",
      "leukemia\n",
      "['clinically', ',', 'oral', 'administration', 'of', 'uft', 'has', 'proved', 'to', 'be', 'effective', 'as', 'an', 'adjuvant', 'therapy', 'after', 'surgery', 'for', 'some', 'malignant', 'tumors', 'such', 'as', 'non-small', 'cell', 'lung', 'cancer']\n",
      "surgery\n",
      "some\n",
      "malignant\n",
      "tumors\n",
      "such\n",
      "as\n",
      "non-small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "['moreover', ',', 'uft', 'has', 'proved', 'to', 'be', 'effective', 'for', 'inoperable', 'advanced', 'malignancies', 'such', 'as', 'colorectal', 'cancer', ',', 'especially', 'in', 'combination', 'with', 'leucovorin', 'or', 'cisplatin']\n",
      "inoperable\n",
      "advanced\n",
      "malignancies\n",
      "such\n",
      "as\n",
      "colorectal\n",
      "cancer\n",
      "combination\n",
      "with\n",
      "leucovorin\n",
      "or\n",
      "cisplatin\n",
      "['the', 'use', 'of', 'topical', 'corticosteroids', 'has', 'revolutionised', 'the', 'treatment', 'of', 'inflammatory', 'skin', 'diseases']\n",
      "topical\n",
      "corticosteroids\n",
      "inflammatory\n",
      "skin\n",
      "diseases\n",
      "['the', 'cancer', 'and', 'leukemia', 'group', 'b', 'performed', 'a', 'series', 'of', 'studies', 'involving', 'sequential', 'chemotherapy', 'followed', 'by', 'radiation', 'for', 'patients', 'with', 'unresectable', 'stage', 'iii', 'nsclc']\n",
      "studies\n",
      "involving\n",
      "sequential\n",
      "chemotherapy\n",
      "unresectable\n",
      "stage\n",
      "iii\n",
      "nsclc\n",
      "['only', '22', 'patients', '(', '10', '%', ')', 'were', 'alive', 'at', 'five', 'years', ':', '19', 'patients', 'with', 'nsclc', 'who', 'had', 'got', 'surgical', 'treatment', ',', 'one', 'patient', 'with', 'nsclc', '(', 'stage', 'iiib', ')', 'who', 'had', 'recieved', 'radiotherapy', ',', 'and', 'two', 'patients', 'with', 'sclc', ',', 'limited', 'disease', ',', 'treated', 'with', 'chemo-', 'and', 'radiotherapy']\n",
      "nsclc\n",
      "got\n",
      "surgical\n",
      "treatment\n",
      "nsclc\n",
      "(\n",
      "stage\n",
      "iiib\n",
      ")\n",
      "sclc\n",
      "radiotherapy\n",
      "['whether', 'the', 'era', 'of', 'platinum-based', 'chemotherapy', 'in', 'the', 'treatment', 'of', 'nsclc', 'should', 'continue', 'or', 'not', 'must', 'be', 'determined', 'by', 'phase', 'iii', 'trials', ',', 'evaluating', 'the', 'use', 'of', 'a', 'platinum', 'agent', 'with', 'one', 'of', 'the', 'new', 'agent', 'combinations']\n",
      "platinum-based\n",
      "chemotherapy\n",
      "nsclc\n",
      "['purpose', ':', 'many', 'patients', 'with', 'locally', 'advanced', 'non-small-cell', 'lung', 'cancer', '(', 'la-nsclc', ')', 'are', 'eligible', 'for', 'combined-modality', 'therapy', '(', 'cmt', ';', 'chemotherapy', 'and', 'radiotherapy', ')']\n",
      "locally\n",
      "advanced\n",
      "non-small-cell\n",
      "lung\n",
      "cancer\n",
      "(\n",
      "la-nsclc\n",
      ")\n",
      "chemotherapy\n",
      "and\n",
      "radiotherapy\n",
      ")\n",
      "['objective', ':', 'to', 'report', 'the', 'use', 'of', 'heparin', 'and', 'enoxaparin', 'for', 'radiation-induced', 'myelopathy']\n",
      "heparin\n",
      "and\n",
      "enoxaparin\n",
      "radiation-induced\n",
      "myelopathy\n",
      "['conclusion', ':', 'vip', 'combination', 'chemotherapy', 'and', 'early', 'concurrent', 'thoracic', 'irradiation', 'for', 'patients', 'with', 'limited', 'stage', 'small', 'cell', 'lung', 'cancer', 'revealed', 'excellent', 'antitumor', 'response', 'with', 'tolerable', 'toxicity']\n",
      "vip\n",
      "combination\n",
      "chemotherapy\n",
      "limited\n",
      "stage\n",
      "small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "['we', 'evaluated', 'the', 'role', 'of', 'systemic', 'chemotherapy', 'for', 'patients', 'with', 'malignant', 'pleural', 'effusions', 'from', 'nsclc']\n",
      "systemic\n",
      "chemotherapy\n",
      "malignant\n",
      "pleural\n",
      "effusions\n",
      "from\n",
      "nsclc\n",
      "['in', 'contrast', ',', 'the', 'introduction', 'and', 'improvement', 'of', 'chemotherapy', 'since', 'the', '1970s', 'gave', 'rise', 'to', 'an', 'improvement', 'in', '-', 'only', 'short-term', '(', '<', '2', 'years', ')', '-', 'survival', 'for', 'patients', 'with', 'small-cell', 'lung', 'cancer']\n",
      "chemotherapy\n",
      "small-cell\n",
      "lung\n",
      "cancer\n",
      "['the', 'degree', 'of', 'healing', 'and', 'damage', 'of', 'the', 'bronchial', 'wall', 'after', 'photodynamic', 'therapy', ',', 'nd-yag', 'laser', 'and', 'electrocautery', 'for', 'intraluminal', 'early-stage', 'cancer', 'have', 'been', 'analysed']\n",
      "photodynamic\n",
      "therapy\n",
      "intraluminal\n",
      "early-stage\n",
      "cancer\n",
      "['to', 'examine', 'whether', 'efficacy', 'of', 'postoperative', 'oral', 'administration', 'of', 'uft', ',', 'a', '5-fluorouracil', 'derivative', 'chemotherapeutic', 'agent', ',', 'may', 'be', 'influenced', 'by', 'incidence', 'of', 'apoptosis', '(', 'apoptosis', 'index', ')', 'or', 'apoptosis-related', 'gene', 'status', '(', 'p53', 'and', 'bcl-2', ')', 'of', 'the', 'tumour', ',', 'a', 'total', 'of', '162', 'patients', 'with', 'pathologic', 'stage', 'i', 'non-small', 'cell', 'lung', 'cancer', 'were', 'retrospectively', 'reviewed']\n",
      "postoperative\n",
      "oral\n",
      "administration\n",
      "pathologic\n",
      "stage\n",
      "i\n",
      "non-small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "['is', 'prolonged', 'survival', 'possible', 'for', 'patients', 'with', 'supraclavicular', 'node', 'metastases', 'in', 'nsclc', 'treated', 'with', 'chemoradiotherapy', '?', 'ijrobp', '1999', ';', '44', '(', '4', ')', ':', '847-853']\n",
      "supraclavicular\n",
      "node\n",
      "metastases\n",
      "in\n",
      "nsclc\n",
      "chemoradiotherapy\n",
      "['we', 'aimed', 'to', 'investigate', 'whether', 'biological', 'factors', 'related', 'to', 'radiosensitivity', 'and', 'chemosensitivity', 'have', 'prognostic', 'significance', 'in', 'non-small-cell-lung-cancer', '(', 'nsclc', ')', 'patients', 'treated', 'with', 'daily', 'low', 'doses', 'of', 'cisplatin', 'and', 'radiotherapy']\n",
      "non-small-cell-lung-cancer\n",
      "(\n",
      "nsclc\n",
      ")\n",
      "cisplatin\n",
      "and\n",
      "radiotherapy\n",
      "['for', 'patients', 'with', 'lung', 'carcinoma', 'who', 'are', 'in', 'relatively', 'poor', 'health', ',', 'the', 'authors', 'chose', 'videothoracoscopic', 'lobectomy', 'or', 'partial', 'resection', 'of', 'the', 'lung', 'instead', 'of', 'an', 'open', 'thoracotomy']\n",
      "lung\n",
      "carcinoma\n",
      "videothoracoscopic\n",
      "lobectomy\n",
      "or\n",
      "partial\n",
      "resection\n",
      "an\n",
      "open\n",
      "thoracotomy\n",
      "['background', ':', 'curative', 'therapy', 'is', 'available', 'for', 'patients', 'with', 'stage', '0', 'lung', 'carcinoma', ',', 'with', 'a', '>', '90', '%', '5-year', 'survival', 'rate']\n",
      "curative\n",
      "therapy\n",
      "stage\n",
      "0\n",
      "lung\n",
      "carcinoma\n",
      "['patients', 'with', 'a', 'single', 'non-sclc', ',', 'breast', ',', 'melanoma', ',', 'renal', 'cell', ',', 'and', 'ovarian', 'carcinoma', 'brain', 'metastasis', 'have', 'the', 'best', 'chance', 'for', 'long-term', 'survival', 'if', 'treated', 'with', 'surgical', 'resection', 'and', 'wbrt']\n",
      "ovarian\n",
      "carcinoma\n",
      "brain\n",
      "metastasis\n",
      "surgical\n",
      "resection\n",
      "['methods', ':', 'over', '90', 'months', ',', 'therapeutic', 'vats', 'metastasectomy', 'was', 'accomplished', 'upon', '80', 'patients', 'with', 'colorectal', 'metastases']\n",
      "therapeutic\n",
      "vats\n",
      "metastasectomy\n",
      "colorectal\n",
      "metastases\n",
      "['patients', 'with', 'limited-stage', 'small-cell', 'carcinoma', 'of', 'the', 'lung', 'are', 'treated', 'with', 'combined-modality', 'therapy', 'with', 'the', 'intent', 'to', 'cure']\n",
      "limited-stage\n",
      "small-cell\n",
      "carcinoma\n",
      "combined-modality\n",
      "therapy\n",
      "['methods', ':', 'we', 'analyzed', '30', 'patients', 'who', 'were', 'discovered', 'to', 'have', 'brain', 'metastases', 'during', 'the', 'diagnosis', 'of', '121', 'patients', 'enrolled', 'in', 'three', 'consecutive', 'clinical', 'trials', 'on', 'advanced', 'nsclc', 'assessing', 'combination', 'chemotherapy', 'of', 'cisplatin', ',', 'ifosfamide', 'and', 'irinotecan', 'with', 'rhg-csf', 'support']\n",
      "advanced\n",
      "nsclc\n",
      "assessing\n",
      "combination\n",
      "chemotherapy\n",
      "of\n",
      "cisplatin\n",
      ",\n",
      "ifosfamide\n",
      "and\n",
      "irinotecan\n",
      "with\n",
      "rhg-csf\n",
      "support\n",
      "['in', 'patients', 'with', 'metastatic', 'colorectal', 'cancer', ',', 'intravenous', 'oxaliplatin', 'has', 'been', 'trialled', 'as', 'a', 'monotherapy', 'and', 'in', 'combination', 'with', 'other', 'agents']\n",
      "metastatic\n",
      "colorectal\n",
      "cancer\n",
      "intravenous\n",
      "oxaliplatin\n",
      "['promising', 'results', 'have', 'also', 'been', 'found', 'with', 'oxaliplatin', 'in', 'patients', 'with', 'non-hodgkin', \"'s\", 'lymphoma', ',', 'breast', 'cancer', ',', 'mesothelioma', 'and', 'non-small', 'cell', 'lung', 'cancer']\n",
      "oxaliplatin\n",
      "non-hodgkin\n",
      "'s\n",
      "lymphoma\n",
      ",\n",
      "breast\n",
      "cancer\n",
      "mesothelioma\n",
      "and\n",
      "non-small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "['additional', 'clinical', 'investigation', 'of', 'oxaliplatin', 'in', 'patients', 'with', 'other', 'cancers', 'is', 'warranted', 'given', 'the', 'promising', 'results', 'achieved', 'in', 'early', 'trials', ',', 'most', 'notably', 'in', 'patients', 'with', 'platinum-pretreated', 'ovarian', 'cancer']\n",
      "oxaliplatin\n",
      "platinum-pretreated\n",
      "ovarian\n",
      "cancer\n",
      "['the', 'drug', 'is', 'currently', 'in', 'phase', 'iii', 'clinical', 'trials', 'for', 'patients', 'with', 'non-small', 'cell', 'lung', 'cancer', 'in', 'combination', 'with', 'paclitaxel', 'and', 'carboplatin', ',', 'as', 'well', 'as', 'in', 'advanced', 'hormone', 'refractory', 'prostate', 'cancer', 'in', 'combination', 'with', 'mitoxantrone']\n",
      "non-small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "combination\n",
      "with\n",
      "paclitaxel\n",
      "and\n",
      "carboplatin\n",
      "advanced\n",
      "hormone\n",
      "refractory\n",
      "prostate\n",
      "cancer\n",
      "['of', '1', ',', '042', 'patients', 'with', 'primary', 'lung', 'cancer', 'who', 'underwent', 'resection', 'from', '1982', 'to', '1995', ',', '549', 'patients', 'with', 'adenocarcinoma', '(', 'ad', ')', 'and', '363', 'with', 'squamous', 'cell', 'carcinoma', '(', 'sq', ')', 'were', 'included', 'in', 'this', 'study']\n",
      "primary\n",
      "lung\n",
      "cancer\n",
      "resection\n",
      "adenocarcinoma\n",
      "squamous\n",
      "cell\n",
      "carcinoma\n",
      "['chemotherapy', 'administered', 'before', 'surgery', 'or', 'definitive', 'irradiation', 'has', 'improved', 'survival', 'rates', 'in', 'patients', 'with', 'stage', 'iii', 'nsclc']\n",
      "chemotherapy\n",
      "administered\n",
      "before\n",
      "surgery\n",
      "stage\n",
      "iii\n",
      "nsclc\n",
      "['objectives', ':', 'this', 'study', 'aims', 'to', 'test', 'whether', 'prophylactic', 'cranial', 'irradiation', 'prolongs', 'survival', 'of', 'patients', 'with', 'small', 'cell', 'lung', 'cancer', 'in', 'complete', 'remission']\n",
      "prophylactic\n",
      "cranial\n",
      "irradiation\n",
      "prolongs\n",
      "small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "['combination', 'chemotherapy', 'is', 'the', 'cornerstone', 'of', 'treatment', 'that', 'confers', 'a', 'meaningful', 'survival', 'benefit', 'for', 'patients', 'with', 'small-cell', 'lung', 'cancer']\n",
      "combination\n",
      "chemotherapy\n",
      "small-cell\n",
      "lung\n",
      "cancer\n",
      "['sample', ':', '45', 'adults', 'with', 'primary', 'cancer', 'of', 'the', 'lung', 'receiving', '<', 'outpatient', 'primary', 'or', 'adjuvant', 'radiation', 'therapy']\n",
      "primary\n",
      "cancer\n",
      "adjuvant\n",
      "radiation\n",
      "therapy\n",
      "['conclusions', ':', 'this', 'study', 'is', 'the', 'first', 'to', 'evaluate', 'planned', 'sequential', 'chemotherapy', 'in', 'patients', 'with', 'nsclc']\n",
      "evaluate\n",
      "planned\n",
      "sequential\n",
      "chemotherapy\n",
      "nsclc\n",
      "['purpose', ':', 'this', 'randomized', 'trial', 'was', 'designed', 'to', 'determine', 'whether', 'paclitaxel', 'plus', 'carboplatin', '(', 'pc', ')', 'offered', 'a', 'survival', 'advantage', 'over', 'vinorelbine', 'plus', 'cisplatin', '(', 'vc', ')', 'for', 'patients', 'with', 'advanced', 'non', '--', 'small-cell', 'lung', 'cancer']\n",
      "determine\n",
      "whether\n",
      "paclitaxel\n",
      "plus\n",
      "carboplatin\n",
      "(\n",
      "pc\n",
      ")\n",
      "vinorelbine\n",
      "plus\n",
      "cisplatin\n",
      "(\n",
      "vc\n",
      ")\n",
      "advanced\n",
      "non\n",
      "--\n",
      "small-cell\n",
      "lung\n",
      "cancer\n",
      "['conclusions', ':', 'the', 'intensification', 'of', 'platinum', 'dose', '(', 'cisplatin', 'plus', 'carboplatin', ')', 'in', 'combination', 'chemotherapy', 'significantly', 'increased', 'the', 'complete', 'response', 'rate', ',', 'overall', 'survival', 'and', 'number', 'of', 'two-year', 'survivors', 'among', 'sclc', 'patients', 'with', 'limited', 'disease', 'compared', 'to', 'combination', 'therapy', 'with', 'carboplatin', 'alone', ',', 'suggesting', 'that', 'a', 'more', 'aggressive', 'treatment', 'to', 'this', 'category', 'of', 'patients', 'is', 'worthwhile', ',', 'while', 'no', 'difference', 'in', 'treatment', 'outcome', 'was', 'observed', 'for', 'patients', 'with', 'extensive', 'disease']\n",
      "platinum\n",
      "dose\n",
      "(\n",
      "cisplatin\n",
      "plus\n",
      "carboplatin\n",
      ")\n",
      "in\n",
      "combination\n",
      "chemotherapy\n",
      "two-year\n",
      "survivors\n",
      "among\n",
      "sclc\n",
      "limited\n",
      "disease\n",
      "combination\n",
      "therapy\n",
      "with\n",
      "carboplatin\n",
      "alone\n",
      "extensive\n",
      "disease\n",
      "['the', 'aim', 'of', 'this', 'study', 'was', 'to', 'investigate', 'the', 'relationships', 'among', 'technetium-99m', 'tetrofosmin', '(', 'tc-tf', ')', 'accumulation', 'in', 'untreated', 'small', 'cell', 'lung', 'cancer', '(', 'sclc', ')', ',', 'the', 'expression', 'of', 'p-glycoprotein', '(', 'pgp', ')', 'and', 'multidrug', 'resistance', 'related', 'protein-1', '(', 'mrp1', ')', ',', 'and', 'the', 'response', 'to', 'chemotherapy', 'in', 'patients', 'with', 'untreated', 'sclc']\n",
      "untreated\n",
      "small\n",
      "cell\n",
      "lung\n",
      "cancer\n",
      "(\n",
      "sclc\n",
      ")\n",
      "chemotherapy\n",
      "untreated\n",
      "sclc\n",
      "['animal', 'studies', 'suggest', 'that', 'the', 'kidney', 'is', 'involved', 'in', 'the', 'elimination', 'of', 'recombinant', 'human', 'granulocyte', 'colony-stimulating', 'factor', '(', 'rhg-csf', ')', ',', 'which', 'is', 'used', 'for', 'patients', 'with', 'neutropenia', 'during', 'cancer', 'chemotherapy']\n",
      "neutropenia\n",
      "during\n",
      "cancer\n",
      "chemotherapy\n",
      "['<', 'TO_SEE', '>', 'in', 'another', 'randomised', 'phase', 'iii', 'trial', 'in', '303', 'patients', 'with', 'head', 'and', 'neck', 'cancer', 'undergoing', 'irradiation', 'therapy', '(', 'total', 'dose', '50', 'to', '70gy', ')', ',', 'pretreatment', 'with', 'intravenous', 'amifostine', '200', 'mg/m2', 'significantly', 'reduced', 'the', 'incidence', 'of', 'acute', 'and', 'late', 'grade', '>', 'or', '=2', 'xerostomia']\n",
      "head\n",
      "and\n",
      "neck\n",
      "cancer\n",
      "irradiation\n",
      "therapy\n",
      "intravenous\n",
      "amifostine\n",
      "=2\n",
      "xerostomia\n",
      "['Ninety-six', 'patients', 'with', 'disseminated', 'malignant', 'melanoma', 'received', 'thrice', 'weekly', 'intramuscular', 'injections', 'of', 'leukocyte', 'A', 'recombinant', 'interferon', '(', 'rIFN-alpha', 'A', ',', 'Roferon-A', ',', 'Hoffmann', 'La', 'Roche', ')', 'at', 'doses', 'of', '12', 'X', '10', '(', '6', ')', 'U/m2', 'or', '50', 'X', '10', '(', '6', ')', 'U/m2', 'with', 'or', 'without', 'cimetidine', 'as', 'an', 'immunorestorative', 'agent']\n",
      "disseminated\n",
      "malignant\n",
      "melanoma\n",
      "leukocyte\n",
      "A\n",
      "recombinant\n",
      "interferon\n",
      "(\n",
      "rIFN-alpha\n",
      "['Ten', 'patients', 'with', 'advanced', 'stage', '(', 'TNM', 'IIB-IVB', ')', 'mycosis', 'fungoides', 'were', 'treated', 'with', 'a', 'combination', 'chemotherapy', 'program', 'consisting', 'of', 'bleomycin', 'and', 'methotrexate', 'weekly', ',', 'doxorubicin', 'every', '3', 'weeks', ',', 'and', 'topical', 'nitrogen', 'mustard', 'daily', '(', 'BAM-M', ')']\n",
      "advanced\n",
      "stage\n",
      "(\n",
      "TNM\n",
      "IIB-IVB\n",
      ")\n",
      "mycosis\n",
      "fungoides\n",
      "a\n",
      "combination\n",
      "chemotherapy\n",
      "bleomycin\n",
      "and\n",
      "methotrexate\n",
      "weekly\n",
      ",\n",
      "doxorubicin\n",
      "every\n",
      "['Guiding', 'surgical', 'therapy', 'of', 'ventricular', 'tachycardia', 'by', 'preoperative', 'endocardial', 'catheter', 'mapping', 'necessitates', 'improvement', 'of', 'the', 'accuracy', 'of', 'localization', 'of', 'the', 'arrhythmogenic', 'site']\n",
      "Guiding\n",
      "surgical\n",
      "therapy\n",
      "ventricular\n",
      "tachycardia\n",
      "['Surgical', 'management', 'of', 'syringomyelia', 'associated', 'with', 'spinal', 'adhesive', 'arachnoiditis']\n",
      "Surgical\n",
      "management\n",
      "spinal\n",
      "adhesive\n",
      "arachnoiditis\n",
      "['Prospective', ',', 'randomized', ',', 'largescale', 'trials', 'supporting', 'any', 'of', 'the', 'different', 'treatment', 'strategies', 'are', 'not', 'available', ',', 'but', 'antibiotics', 'and', 'surgery', 'probably', 'have', 'improved', 'the', 'long-term', 'outcome', 'of', 'many', 'patients', 'with', 'bronchiectasis']\n",
      "antibiotics\n",
      "and\n",
      "surgery\n",
      "bronchiectasis\n",
      "['Cholecystectomy', 'should', 'be', 'a', 'first-line', 'therapy', 'for', 'biliary', 'dyskinesia', 'patients']\n",
      "Cholecystectomy\n",
      "first-line\n",
      "therapy\n",
      "biliary\n",
      "dyskinesia\n",
      "['Effectiveness', 'of', 'pseudoephedrine', 'plus', 'acetaminophen', 'for', 'treatment', 'of', 'symptoms', 'attributed', 'to', 'the', 'paranasal', 'sinuses', 'associated', 'with', 'the', 'common', 'cold']\n",
      "pseudoephedrine\n",
      "plus\n",
      "acetaminophen\n",
      "the\n",
      "common\n",
      "cold\n",
      "['PURPOSE', ':', 'Macrolide', 'antibiotics', 'are', 'frequently', 'prescribed', 'to', 'patients', 'with', 'symptoms', 'of', 'a', 'common', 'cold']\n",
      "Macrolide\n",
      "antibiotics\n",
      "symptoms\n",
      "of\n",
      "a\n",
      "common\n",
      "cold\n",
      "['Because', 'the', 'symptoms', 'of', 'rhinovirus', 'colds', 'are', 'attributed', 'to', 'the', 'inflammatory', 'response', 'to', 'infection', ',', 'we', 'studied', 'the', 'effects', 'of', 'treatment', 'with', 'clarithromycin', 'on', 'the', 'symptomatic', 'and', 'inflammatory', 'response', 'to', 'nasal', 'inoculation', 'with', 'rhinovirus']\n",
      "clarithromycin\n",
      "rhinovirus\n",
      "['Patients', 'with', 'evidence', 'of', 'infection', 'with', 'H.', 'pylori', 'were', 'treated', 'with', 'a', 'combination', 'of', 'omeprazole', ',', 'amoxicillin', ',', 'and', 'clarithromycin']\n",
      "infection\n",
      "a\n",
      "combination\n",
      "of\n",
      "omeprazole\n",
      ",\n",
      "amoxicillin\n",
      ",\n",
      "and\n",
      "clarithromycin\n",
      "['Contemporary', 'asthma', 'management', 'guidelines', 'list', 'inhaled', 'corticosteroids', 'as', 'the', 'preferred', 'controller', 'medication', 'for', 'patients', 'with', 'persistent', 'asthma']\n",
      "Contemporary\n",
      "asthma\n",
      "management\n",
      "guidelines\n",
      "list\n",
      "inhaled\n",
      "corticosteroids\n",
      "persistent\n",
      "asthma\n",
      "['Fluticasone', 'propionate', 'is', 'one', 'of', 'several', 'inhaled', 'corticosteroids', 'used', 'for', 'the', 'treatment', 'of', 'asthma']\n",
      "Fluticasone\n",
      "propionate\n",
      "several\n",
      "inhaled\n",
      "corticosteroids\n",
      "asthma\n",
      "['Combination', 'therapy', 'with', 'interferon-alpha', '(', 'IFN', 'alpha', ')', 'plus', 'Ribavirin', 'has', 'been', 'shown', 'to', 'improve', 'the', 'response', 'rate', 'in', 'patients', 'with', 'chronic', 'hepatitis', 'C', 'as', 'compared', 'to', 'IFN', 'alpha', 'alone']\n",
      "Combination\n",
      "therapy\n",
      "with\n",
      "interferon-alpha\n",
      "(\n",
      "IFN\n",
      "alpha\n",
      ")\n",
      "plus\n",
      "Ribavirin\n",
      "chronic\n",
      "hepatitis\n",
      "C\n",
      "['To', 'prove', ',', 'whether', 'Ribavirin', 'has', 'any', 'additional', 'effect', 'on', 'the', 'decline', 'of', 'hepatitis', 'C', 'viremia', 'during', 'the', 'first', 'weeks', 'of', 'treatment', 'patients', 'with', 'and', 'without', 'combination', 'therapy', 'were', 'compared']\n",
      "hepatitis\n",
      "C\n",
      "viremia\n",
      "combination\n",
      "therapy\n",
      "['He', 'needed', 'mechanical', 'ventilation', 'for', 'severe', 'hypoxemia', ',', 'but', 'recovered', 'with', 'glucocorticoid', 'pulse', 'therapy']\n",
      "severe\n",
      "hypoxemia\n",
      "glucocorticoid\n",
      "pulse\n",
      "therapy\n",
      "['OBJECTIVE', ':', 'This', 'study', 'was', 'designed', 'to', 'evaluate', 'the', 'safety', 'and', 'estimate', 'the', 'efficacy', 'of', 'oral', 'budesonide', 'in', 'patients', 'with', 'primary', 'sclerosing', 'cholangitis', '(', 'PSC', ')']\n",
      "oral\n",
      "budesonide\n",
      "primary\n",
      "sclerosing\n",
      "cholangitis\n",
      "(\n",
      "PSC\n",
      ")\n",
      "['Thrombolytic', 'therapy', 'has', 'been', 'accepted', 'in', 'the', 'treatment', 'of', 'acute', 'myocardial', 'infarction']\n",
      "Thrombolytic\n",
      "therapy\n",
      "acute\n",
      "myocardial\n",
      "infarction\n",
      "['Touch', 'sensibility', 'was', 'assessed', 'with', 'von', 'Frey', \"'s\", 'monofilaments', 'in', 'the', 'breasts', 'of', '10', 'healthy', 'women', '(', 'controls', ')', 'and', 'of', '80', 'women', 'with', 'breast', 'cancer', 'who', 'at', 'least', '1', 'year', 'previously', 'had', 'undergone', 'subcutaneous', 'mastectomy', 'and', 'immediate', 'reconstruction', 'with', 'a', 'prosthesis']\n",
      "breast\n",
      "cancer\n",
      "undergone\n",
      "subcutaneous\n",
      "mastectomy\n",
      "and\n",
      "immediate\n",
      "reconstruction\n",
      "['Immunotherapy', 'of', 'mice', 'with', 'preexisting', 'cancers', 'with', 'heat', 'shock', 'protein', 'preparations', 'derived', 'from', 'autologous', 'cancer', 'resulted', 'in', 'retarded', 'progression', 'of', 'the', 'primary', 'cancer', ',', 'a', 'reduced', 'metastatic', 'load', ',', 'and', 'prolongation', 'of', 'life-span']\n",
      "Immunotherapy\n",
      "primary\n",
      "cancer\n",
      "['<', 'TO_SEE', '>', 'CONCLUSION', ':', 'Direct', 'PTA', 'may', 'be', 'performed', 'safely', 'as', 'an', 'alternative', 'to', 'thrombolytic', 'therapy', 'in', 'patients', 'with', 'acute', 'occlusion', 'of', 'the', 'middle', 'cerebral', 'artery', 'when', 'early', 'CT', 'findings', 'and/or', 'lenticulostriate', 'artery', 'involvement', 'are', 'present', 'or', 'when', 'superselective', 'local', 'angiography', 'shows', 'the', 'presence', 'of', 'a', 'large', 'embolus', 'or', 'high-grade', 'stenosis']\n",
      "thrombolytic\n",
      "therapy\n",
      "acute\n",
      "occlusion\n",
      "middle\n",
      "cerebral\n",
      "artery\n",
      "when\n",
      "early\n",
      "CT\n",
      "findings\n",
      "and/or\n",
      "lenticulostriate\n",
      "artery\n",
      "high-grade\n",
      "stenosis\n",
      "['As', 'the', 'overview', 'shows', ',', 'both', 'groups', 'of', 'substances', 'are', 'useful', 'for', 'individualized', 'treatment', 'of', 'benign', 'prostatic', 'hyperplasia', '(', 'BPH', ')', ',', 'provided', 'that', 'conservative', 'pharmacological', 'treatment', 'of', 'BPH', 'is', 'basically', 'accepted', 'and', 'that', 'the', 'patients', \"'\", 'quality', 'of', 'life', 'is', 'also', 'considered']\n",
      "benign\n",
      "prostatic\n",
      "hyperplasia\n",
      "conservative\n",
      "pharmacological\n",
      "treatment\n",
      "['High-dose', 'intravenous', 'immunoglobulin', '(', 'hdIVIg', ')', 'is', 'increasingly', 'used', 'to', 'treat', 'a', 'range', 'of', 'inflammatory', 'and', 'autoimmune', 'diseases']\n",
      "High-dose\n",
      "intravenous\n",
      "immunoglobulin\n",
      "(\n",
      "hdIVIg\n",
      ")\n",
      "autoimmune\n",
      "diseases\n",
      "['While', 'these', 'findings', 'are', 'observed', 'for', 'all', 'classes', 'of', 'oral', 'drugs', ',', 'the', 'issue', 'is', 'especially', 'critical', 'for', 'cancer', 'chemotherapy', ',', 'in', 'which', 'a', 'narrow', 'therapeutic', 'index', 'is', 'frequently', 'observed']\n",
      "oral\n",
      "drugs\n",
      "cancer\n",
      "chemotherapy\n",
      "['BACKGROUND', ':', 'Adrenalectomy', 'is', 'the', 'current', 'treatment', 'for', 'phaeochromocytoma']\n",
      "Adrenalectomy\n",
      "phaeochromocytoma\n",
      "['As', 'single', 'agent', 'therapy', 'in', 'malignant', 'melanoma', ',', 'interferon', 'alfa-2a', 'was', 'only', 'marginally', 'useful', 'in', 'most', 'patients']\n",
      "malignant\n",
      "melanoma\n",
      "interferon\n",
      "alfa-2a\n",
      "['Studies', 'with', 'various', 'interferon', 'alpha', 'preparations', ',', 'including', 'interferons', 'induced', 'in', 'human', 'leukocytes', ',', 'interferon', 'alfa-N1', ',', 'interferon', 'alfa-2a', ',', 'and', 'interferon', 'alfa-2b', ',', 'have', 'all', 'provided', 'evidence', 'for', 'modest', 'but', 'reproducible', 'antitumor', 'activity', 'in', 'advanced', 'renal', 'cell', 'carcinoma']\n",
      "various\n",
      "interferon\n",
      "alpha\n",
      "preparations\n",
      "interferon\n",
      "alfa-N1\n",
      ",\n",
      "interferon\n",
      "alfa-2a\n",
      ",\n",
      "and\n",
      "interferon\n",
      "alfa-2b\n",
      "advanced\n",
      "renal\n",
      "cell\n",
      "carcinoma\n",
      "['The', 'rationale', 'for', 'antileukemic', 'therapy', 'in', 'hairy', 'cell', 'leukemia', 'is', 'to', 'reduce', 'the', 'significant', 'risk', 'of', 'infection', 'and', 'other', 'potential', 'serious', 'complications']\n",
      "antileukemic\n",
      "therapy\n",
      "hairy\n",
      "cell\n",
      "leukemia\n",
      "infection\n",
      "['Recombinant', 'and', 'natural', 'forms', 'of', 'interferon', 'alpha', 'have', 'been', 'shown', 'to', 'bring', 'about', 'tumor', 'regressions', 'in', 'patients', 'with', 'low-grade', 'non-Hodgkin', \"'s\", 'lymphoma']\n",
      "interferon\n",
      "alpha\n",
      "low-grade\n",
      "non-Hodgkin\n",
      "'s\n",
      "lymphoma\n",
      "['OBJECTIVE', ':', 'We', 'report', 'the', 'results', 'of', 'a', 'double-blind', ',', 'double-dummy', ',', 'active-control', 'study', 'designed', 'to', 'evaluate', 'the', 'efficacy', 'and', 'safety', 'of', 'lamotrigine', '(', 'LTG', ')', 'administered', 'as', 'monotherapy', 'to', 'adult', 'outpatients', 'with', 'partial', 'seizures']\n",
      "lamotrigine\n",
      "(\n",
      "LTG\n",
      ")\n",
      "partial\n",
      "seizures\n",
      "['This', 'article', 'reviews', 'current', 'trends', 'in', 'management', 'of', 'esophageal', 'achalasia', ',', 'highlighting', 'short-term', 'outcome', 'and', 'cost', 'comparisons', 'of', 'three', 'treatments', ':', 'botulinum', 'toxin', 'injection', ',', 'pneumatic', 'dilation', ',', 'and', 'laparoscopic', 'myotomy']\n",
      "esophageal\n",
      "achalasia\n",
      "botulinum\n",
      "toxin\n",
      "injection\n",
      ",\n",
      "pneumatic\n",
      "dilation\n",
      ",\n",
      "and\n",
      "laparoscopic\n",
      "myotomy\n",
      "['Comparison', 'of', 'radical', 'prostatectomy', 'and', 'iodine', '125', 'interstitial', 'radiotherapy', 'for', 'the', 'treatment', 'of', 'clinically', 'localized', 'prostate', 'cancer', ':', 'a', '7-year', 'biochemical', '(', 'PSA', ')', 'progression', 'analysis']\n",
      "radical\n",
      "prostatectomy\n",
      "and\n",
      "iodine\n",
      "125\n",
      "interstitial\n",
      "radiotherapy\n",
      "prostate\n",
      "cancer\n",
      "['Effect', 'of', 'photodynamic', 'therapy', 'in', 'combination', 'with', 'mitomycin', 'C', 'on', 'a', 'mitomycin-resistant', 'bladder', 'cancer', 'cell', 'line']\n",
      "photodynamic\n",
      "therapy\n",
      "in\n",
      "combination\n",
      "with\n",
      "mitomycin\n",
      "C\n",
      "mitomycin-resistant\n",
      "bladder\n",
      "cancer\n",
      "['In', 'vitro', 'and', 'in', 'vivo', 'comparison', 'between', 'the', 'effects', 'of', 'treatment', 'with', 'adenosine', 'triphosphate', 'and', 'treatment', 'with', 'buthionine', 'sulfoximine', 'on', 'chemosensitization', 'and', 'tumour', 'growth', 'of', 'B16', 'melanoma']\n",
      "adenosine\n",
      "triphosphate\n",
      "and\n",
      "treatment\n",
      "with\n",
      "buthionine\n",
      "sulfoximine\n",
      "B16\n",
      "melanoma\n",
      "['Effects', 'of', 'transpupillary', 'thermotherapy', 'on', 'immunological', 'parameters', 'and', 'apoptosis', 'in', 'a', 'case', 'of', 'primary', 'uveal', 'melanoma']\n",
      "transpupillary\n",
      "thermotherapy\n",
      "primary\n",
      "uveal\n",
      "melanoma\n",
      "['Current', 'surgical', 'therapy', 'for', 'bronchiectasis']\n",
      "Current\n",
      "surgical\n",
      "therapy\n",
      "bronchiectasis\n",
      "['Antiplatelet', 'therapy', 'in', 'acute', 'cerebral', 'ischemia']\n",
      "Antiplatelet\n",
      "therapy\n",
      "acute\n",
      "cerebral\n",
      "ischemia\n",
      "['Interferon', 'treatment', 'of', 'renal', 'cell', 'carcinoma']\n",
      "Interferon\n",
      "treatment\n",
      "renal\n",
      "cell\n",
      "carcinoma\n",
      "['An', 'active-control', 'trial', 'of', 'lamotrigine', 'monotherapy', 'for', 'partial', 'seizures']\n",
      "lamotrigine\n",
      "monotherapy\n",
      "partial\n",
      "seizures\n",
      "['Gene', 'therapy', 'for', 'myocardial', 'angiogenesis']\n",
      "Gene\n",
      "therapy\n",
      "myocardial\n",
      "angiogenesis\n",
      "['The', 'treatment', 'of', 'autoimmune', 'hemolytic', 'anemia', 'with', 'heparin']\n",
      "autoimmune\n",
      "hemolytic\n",
      "anemia\n",
      "heparin\n",
      "['Glutathione', 'S-transferase', 'activity', 'in', 'epithelial', 'ovarian', 'cancer', ':', 'association', 'with', 'response', 'to', 'chemotherapy', 'and', 'disease', 'outcome']\n",
      "epithelial\n",
      "ovarian\n",
      "cancer\n",
      "chemotherapy\n",
      "['5-year', 'outcome', 'of', 'surgical', 'resection', 'and', 'watchful', 'waiting', 'for', 'men', 'with', 'moderately', 'symptomatic', 'benign', 'prostatic', 'hyperplasia', ':', 'a', 'Department', 'of', 'Veterans', 'Affairs', 'cooperative', 'study']\n",
      "surgical\n",
      "resection\n",
      "moderately\n",
      "symptomatic\n",
      "benign\n",
      "prostatic\n",
      "hyperplasia\n",
      "['Interferon', 'beta', 'treatment', 'for', 'multiple', 'sclerosis']\n",
      "Interferon\n",
      "beta\n",
      "treatment\n",
      "multiple\n",
      "sclerosis\n",
      "['Intravenous', 'immunoglobulin', 'treatment', 'in', 'multiple', 'sclerosis']\n",
      "Intravenous\n",
      "immunoglobulin\n",
      "treatment\n",
      "multiple\n",
      "sclerosis\n",
      "['Stereotactic', 'radiosurgery', 'for', 'acoustic', 'neuroma', ':', 'a', 'Canadian', 'perspective']\n",
      "Stereotactic\n",
      "radiosurgery\n",
      "acoustic\n",
      "neuroma\n",
      "['Hyperbaric', 'oxygen', 'therapy', 'for', 'children', 'with', 'cerebral', 'palsy']\n",
      "Hyperbaric\n",
      "oxygen\n",
      "therapy\n",
      "cerebral\n",
      "palsy\n",
      "['Peripheral', 'retinal', 'cryotherapy', 'for', 'postvitrectomy', 'diabetic', 'vitreous', 'hemorrhage', 'in', 'phakic', 'patients']\n",
      "Peripheral\n",
      "retinal\n",
      "cryotherapy\n",
      "postvitrectomy\n",
      "diabetic\n",
      "vitreous\n",
      "hemorrhage\n",
      "['A', 'randomized', ',', 'controlled', 'study', 'in', 'adults', 'of', 'the', 'immunogenicity', 'of', 'a', 'novel', 'hepatitis', 'B', 'vaccine', 'containing', 'MF59', 'adjuvant']\n",
      "hepatitis\n",
      "B\n",
      "vaccine\n",
      "['The', 'outcome', 'of', 'arthroscopic', 'treatment', 'of', 'temporomandibular', 'joint', 'arthropathy']\n",
      "arthroscopic\n",
      "treatment\n",
      "temporomandibular\n",
      "joint\n",
      "arthropathy\n",
      "['Surgical', 'management', 'of', 'severe', 'secondary', 'peritonitis']\n",
      "Surgical\n",
      "management\n",
      "severe\n",
      "secondary\n",
      "peritonitis\n",
      "['Hepatic', 'arterial', 'infusion', 'of', 'chemotherapy', 'after', 'resection', 'of', 'hepatic', 'metastases', 'from', 'colorectal', 'cancer']\n",
      "Hepatic\n",
      "arterial\n",
      "infusion\n",
      "of\n",
      "chemotherapy\n",
      "after\n",
      "resection\n",
      "hepatic\n",
      "metastases\n",
      "from\n",
      "colorectal\n",
      "cancer\n",
      "['Epoetin', ':', 'a', 'pharmacoeconomic', 'review', 'of', 'its', 'use', 'in', 'chronic', 'renal', 'failure', 'and', 'its', 'effects', 'on', 'quality', 'of', 'life']\n",
      "Epoetin\n",
      "chronic\n",
      "renal\n",
      "failure\n",
      "['High-dose', 'chemotherapy', 'with', 'autologous', 'stem-cell', 'support', 'for', 'epithelial', 'ovarian', 'cancer']\n",
      "High-dose\n",
      "chemotherapy\n",
      "epithelial\n",
      "ovarian\n",
      "cancer\n"
     ]
    }
   ],
   "source": [
    "diseases = []\n",
    "treatments = []\n",
    "counter = 0\n",
    "for l in Y_pred:\n",
    "    if 'D' in l and 'T' in l:\n",
    "        treatment = ''\n",
    "        disease = ''\n",
    "        sent = test_sentences_list[counter].split()\n",
    "        print(sent)\n",
    "        \n",
    "        for index, i in enumerate(l):\n",
    "            if i == 'D':\n",
    "                print(sent[index])\n",
    "                disease = disease + sent[index] + ' '\n",
    "                \n",
    "            if i == 'T':\n",
    "                print(sent[index])\n",
    "                treatment = treatment + sent[index] + ' '\n",
    "                \n",
    "        diseases.append(disease.strip(','))\n",
    "        treatments.append(treatment.strip(','))\n",
    "    \n",
    "    counter += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 157,
   "metadata": {},
   "outputs": [],
   "source": [
    "final_output = pd.DataFrame({'Disease':diseases, 'Treatment':treatments})"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "TvTodSY5OfZ9"
   },
   "source": [
    "### Predict the treatment for the disease name: 'hereditary retinoblastoma'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 158,
   "metadata": {
    "id": "uZNBLMFYVuhv"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Disease</th>\n",
       "      <th>Treatment</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>hereditary retinoblastoma</td>\n",
       "      <td>radiotherapy</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Disease      Treatment\n",
       "0  hereditary retinoblastoma   radiotherapy "
      ]
     },
     "execution_count": 158,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final_output[final_output['Disease'].str.contains('hereditary retinoblastoma')]"
   ]
  }
 ],
 "metadata": {
  "colab": {
   "collapsed_sections": [],
   "name": "Assignment.ipynb",
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
